Scinai Immunotherapeutics (SCNI) Short-term Investments (2015 - 2026)

Scinai Immunotherapeutics (SCNI) has 9 years of Short-term Investments data on file, last reported at $151.0 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments changed N/A year-over-year to $151.0 million; the trailing twelve-month figure through Mar 2026 stood at $151.0 million (changed N/A YoY), and the FY2025 full-year result was $150.0 million, up 114403.82% from the prior year.
• Short-term Investments improved to $151.0 million in Q1 2026, from $150.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $151.0 million in Q1 2026 to a low of $122000.0 in Q3 2023.
• A 5-year average of $21.6 million and a median of $138000.0 in 2022 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments dropped 10.29% in 2023 and surged 114403.82% in 2025, its largest moves.
• Tracing SCNI's Short-term Investments over 5 years: stood at $140000.0 in 2022, then changed by 0.0% to $140000.0 in 2023, then declined by 6.43% to $131000.0 in 2024, then surged by 114403.82% to $150.0 million in 2025, then gained by 0.67% to $151.0 million in 2026.
• Business Quant data shows SCNI's Short-term Investments at $151.0 million in Q1 2026, $150.0 million in Q4 2025, and $142000.0 in Q2 2025.